Archives
-
MoCul4–MoKmt1 Control of Rice Blast Virulence
2026-09-18
The reference study identifies a functional connection between the Cullin4 component MoCul4 and the histone methyltransferase MoKmt1 in Magnaporthe oryzae. Loss of either factor reduces H3K9 trimethylation, disrupts heterochromatin-associated gene regulation, and impairs fungal growth, development, and pathogenicity, providing a mechanistic basis for studying epigenetic control of rice blast.
-
Spleen-Targeted Neoantigen mRNA Vaccine in HCC
2026-09-18
Lin et al. developed a spleen-targeted neoantigen mRNA vaccine that generated ISG15-positive CD8-positive T cells and promoted tertiary lymphoid structure formation in hepatocellular carcinoma. The study links GZMA-F2R signaling between these T cells and antigen-presenting cells to improved antitumor immunity, while highlighting spleen-selective delivery as a major design variable for RNA vaccine development.
-
2'-O-Methyladenosine: Practical Assay Workflows
2026-09-17
Use 2'-O-Methyladenosine as a defined analytical reference, metabolic perturbation probe, or nucleoside analog research scaffold. This guide connects matrix-aware UHPLC–MS/MS, cell-based transport experiments, RNA modification studies, and practical troubleshooting without confusing an exogenous nucleoside treatment with direct RNA incorporation.
-
HEY2, Mitochondrial Respiration, and Cardiac Homeostasis
2026-09-17
The reference study identifies HEY2 as a transcriptional brake on mitochondrial oxidative metabolism in cardiomyocytes. By integrating genetic models, genome-wide analyses, functional respiration assays, rescue experiments, and a doxorubicin injury model, it defines a HEY2/HDAC1–Ppargc1/Cpt regulatory module that links transcriptional control to cardiac energy balance.
-
Bufuralol in hiPSC Intestinal Pharmacokinetics
2026-09-16
Bufuralol hydrochloride offers a mechanistically informative probe for connecting β-adrenergic pharmacology with human intestinal absorption and metabolism. By pairing its non-selective receptor activity and partial intrinsic sympathomimetic properties with human iPSC-derived intestinal organoids, translational researchers can separate receptor pharmacology from exposure, transport, and metabolic effects.
-
Thiazovivin: ROCK Inhibitor Workflow Guide
2026-09-16
Thiazovivin (SKU A5506) is a ROCK inhibitor used to support fibroblast reprogramming for induced pluripotent stem cell generation and improve human embryonic stem cell survival after trypsinization. It is intended for controlled stem cell research workflows only, not for diagnostic, therapeutic, or clinical use.
-
1-Phenyl-2-Pentanol and Liver Fibrosis
2026-09-15
The reference study identifies 1-Phenyl-2-pentanol from Moringa oleifera and evaluates its ability to suppress profibrotic activation of human hepatic stellate cells. By combining cellular assays, gene and protein measurements, proteomics, and molecular docking, the authors connect the observed effects with TGF-β1 and Wnt/β-catenin signaling while defining important limits for translation beyond in vitro liver models.
-
ISRIB (trans-isomer) for ER Stress Research
2026-09-15
ISRIB (trans-isomer) gives researchers a practical way to restore translation downstream of eIF2α phosphorylation while testing how the integrated stress response shapes ER stress, apoptosis, and memory retention. Its eIF2B-centered mechanism supports both cell-based pathway dissection and carefully controlled behavioral studies.
-
BOP Reagent: Coupling for Reliable Cell Studies
2026-09-14
This scenario-driven guide explains how BOP reagent supports carboxyl activation, phenyl ester preparation, and amide bond formation upstream of cell viability and cytotoxicity studies. It also provides practical handling guidance for SKU A7015 while clearly separating synthetic chemistry evidence from biological assay validation.
-
Angiotensin III: RAAS Workflows and Assay Tips
2026-09-14
Build more interpretable RAAS experiments with Angiotensin III, a high-purity peptide for receptor signaling, aldosterone, renin, cardiovascular, and neuroendocrine studies. A practical workflow connects controlled peptide handling with recent evidence on angiotensin-dependent spike-receptor binding while clearly separating established biology from exploratory applications.
-
TRIM66 and Monogenic Olfactory Receptor Expression
2026-09-13
This Nature Communications study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence extra receptor genes and maintain one-neuron-one-receptor expression. Its genetic, molecular, single-cell, neural-activity, and behavioral evidence links receptor-choice fidelity to olfactory circuit function and behavior.
-
Tobramycin Workflows for Bacterial Research
2026-09-12
Build reproducible aqueous susceptibility, mechanism, and resistance workflows with Tobramycin, a water-soluble aminoglycoside antibiotic and bacterial protein synthesis inhibitor. The article translates historical clinical-isolate evidence into practical assay design while emphasizing controls, solvent compatibility, storage, and interpretation limits.
-
Dose-Sparing Self-Amplifying RNA Influenza Vaccines
2026-09-11
This study shows that self-amplifying RNA can address a major influenza B immunogenicity gap observed with conventional nucleoside-modified mRNA vaccines. In mice, a 0.1 μg trivalent self-amplifying RNA formulation generated durable antibody responses and complete protection against influenza B challenge, supporting dose-sparing development while emphasizing the need to separate RNA platform effects from RNA chemistry.
-
mCherry mRNA for Kidney-Targeted Nanoparticle Studies
2026-09-11
Discover how mCherry mRNA can function not only as a fluorescent reporter, but also as a practical probe of nanoparticle loading, uptake, release, and translation. This formulation-aware guide connects EZ Cap™ design features with findings from a kidney-targeted mesoscale nanoparticle study.
-
TCAIM Controls OGDH and Mitochondrial Metabolism
2026-09-10
A 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. This mechanism links mitochondrial proteostasis to control of OGDH complex activity, carbohydrate catabolism, and broader metabolic state in cells and mice.